Guidant Pixel
This article was originally published in The Gray Sheet
Executive Summary
Stent for treatment of small coronary vessels will debut in U.S. later this month in diameters of 2.0 mm, 2.25 mm and 2.5 mm. FDA approval via PMA supplement, announced July 9, allows use for abrupt or threatened closure due to unsuccessful interventional therapy in de novo and restenotic native coronary artery lesions. Device was launched in Europe earlier this year
You may also be interested in...
Small-Vessel Pixel Stent Receives Alloy Upgrade In Next Generation – Guidant
Guidant expects FDA approval of its next-generation Pixel stent for small vessels within the coming weeks
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.